NovaBay Pharma (NBY) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Operating income (loss): -2.01M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Operating income (loss): -2.01M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.01 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance
- Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
